1.
Woon DT, Chandrasekar T, Aaron L, Basappa NS, Chi KN, Conter HJ, et al. Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces. CUAJ [Internet]. 2018 Jul. 16 [cited 2026 Jun. 3];12(10). Available from: https://cuaj.ca/index.php/journal/article/view/5378